Updated efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in metastatic melanoma patients previously treated with anti-PD-1 therapy

Prashanth Prithviraj; Grant McArthur; Victoria Atkinson; Phillip Parente; Miles Andrews; Sagun Parakh; Michael Millward; Jonathan Cebon; Oliver Klein

首页> 外文期刊>Journal for ImmunoTherapy of Cancer >Updated efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in metastatic melanoma patients previously treated with anti-PD-1 therapy

【24h】

Updated efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in metastatic melanoma patients previously treated with anti-PD-1 therapy

机译：抗CTLA-4抗体ipilimumab在先前接受过抗PD-1治疗的转移性黑色素瘤患者中治疗的最新疗效和毒性

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal for ImmunoTherapy of Cancer》 |2015年第s2期|共页
作者
Prashanth Prithviraj; Grant McArthur; Victoria Atkinson; Phillip Parente; Miles Andrews; Sagun Parakh; Michael Millward; Jonathan Cebon; Oliver Klein;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Reply to ‘Comment on ‘Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy'' [J] . Samantha Bowyer, Prashanth Prithviraj, Paul Lorigan, British Journal of Cancer . 2017,第8期

机译：答复“关于”在接受抗PD-1治疗后转移性黑色素瘤患者中抗CTLA-4抗体ipilimumab治疗的疗效和毒性的评论”
2. Comment on ‘Efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in patients with metastatic melanoma after prior anti-PD-1 therapy' [J] . Keisuke Imafuku, Koji Yoshino, Kei Yamaguchi, British Journal of Cancer . 2017,第8期

机译：评论“抗CTLA-4抗体伊匹单抗治疗既往抗PD-1治疗后的转移性黑色素瘤患者的疗效和毒性”
3. Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: Clinical and immunological evidence from three patient cases [J] . DiGiacomoA.M., DanielliR., GuidoboniM., Cancer immunology, immunotherapy : . 2009,第8期

机译：抗CTLA-4单克隆抗体ipilimumab在对先前全身治疗无反应的转移性黑色素瘤患者中的治疗效果：三例患者的临床和免疫学证据
4. Preliminary results of a phase I/II clinical trial using in situ photoimmunotherapy combined with imiquimod for metastatic melanoma patients [C] . Xiaosong Li, Mark F. Naylor, Robert E. Nordquist, . 2010

机译：使用原位光免疫疗法联合咪喹莫特治疗转移性黑色素瘤患者的I / II期临床试验的初步结果
5. Predicting Response to Anti-PD-1 Immunotherapy in Metastatic Melanoma. [D] . Smithy, James William. 2017

机译：预测转移性黑色素瘤中抗PD-1免疫疗法的反应。
6. Updated efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in metastatic melanoma patients previously treated with anti-PD-1 therapy [O] . Prashanth Prithviraj, Grant McArthur, Victoria Atkinson, 2015

机译：抗CTLA-4抗体ipilimumab在先前接受抗PD-1治疗的转移性黑色素瘤患者中治疗的最新疗效和毒性
7. Updated efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in metastatic melanoma patients previously treated with anti-PD-1 therapy [O] . 2015

机译：抗CTLA-4抗体ipilimumab在先前接受抗PD-1治疗的转移性黑色素瘤患者中治疗的最新疗效和毒性

Updated efficacy and toxicity of treatment with the anti-CTLA-4 antibody ipilimumab in metastatic melanoma patients previously treated with anti-PD-1 therapy

著录项

相似文献

相关主题

期刊订阅